16
Maternal, Infant, and Child Health
Co-Lead Agencies:	Centers for Disease Control and Prevention 
Health Resources and Services Administration
Goal
Overview
Issues and Trends
Disparities
Opportunities
Interim Progress Toward Year 2000 Objectives
Healthy People 2010—Summary of Objectives
Healthy People 2010 Objectives
Fetal, Infant, Child, and Adolescent Deaths
Maternal Deaths and Illnesses
Prenatal Care
Obstetrical Care
Risk Factors
Developmental Disabilities and Neural Tube Defects

Prenatal Substance Exposure
Breastfeeding, Newborn Screening, and Service Systems
Related Objectives From Other Focus Areas
Terminology
References

Goal
Improve the health and well-being of women, infants, 
children, and families.
Overview
The health of mothers, infants, and children is of critical importance, both as a reflection of the current health status of a large segment of the U.S. population and as a predictor of the health of the next generation. This focus area addresses a range of indicators of maternal, infant, and child health—those primarily affecting pregnant and postpartum women (including indicators of maternal illness and death) and those that affect infants’ health and survival (including infant mortality rates; birth outcomes; prevention of birth defects; access to preventive care; and fetal, perinatal, and other infant deaths). 
Infant mortality is an important measure of a nation’s health and a worldwide indicator of health status and social well-being. As of 1995, the U.S. infant mortality rates ranked 25th among industrialized nations. In the past decade, critical measures of increased risk of infant death, such as new cases of low birth weight (LBW) and very low birth weight (VLBW), actually have increased in the United States. In addition, the disparity in infant mortality rates between whites and specific racial and ethnic groups (especially African Americans, American Indians or Alaska Natives, Native Hawaiians, and Puerto Ricans) persists. Although the overall infant mortality rate has reached record low levels, the rate for African Americans remains twice that of whites.
Issues and Trends
In 1997, 28,045 infants died before their first birthday, for an overall rate of 7.2 deaths per 1,000 live births. This rate has declined steadily over the past 20 years; in 1975, the infant mortality rate was over 15 per 1,000 live births.2 In 1997, two-thirds of all infant deaths took place during the first 28 days of life (the neonatal period). The overall neonatal mortality rate in 1997 was 4.8 per 1,000 live births.2 The remaining one-third of infant deaths took place during the postneonatal period from an infant’s 29th day of life until the first birthday. The U.S. postneonatal mortality rate in 1997 was 2.4 deaths per 1,000 live births.2
Four causes account for more than half of all infant deaths: birth defects, disorders relating to short gestation and unspecified LBW, sudden infant death syndrome (SIDS), and respiratory distress syndrome. The leading causes of neonatal death in 1997 were birth defects, disorders related to short gestation and LBW, respiratory distress syndrome, and maternal complications of pregnancy. After the first month of life, SIDS is the leading cause of infant death, accounting for about one-third of all deaths during this period. Maternal age also is a risk factor for infant death. Mortality rates are highest among infants born to young teenagers (aged 16 years and under) and to mothers aged 44 years and older.

The death of fetuses before birth is another important indicator of perinatal health. In 1996, nearly 7 fetal deaths were reported for every 1,000 live births and fetal deaths combined, representing a slight decline from the fetal mortality rate of 7.6 per 1,000 in 1987.2 Fetal death sometimes is associated with pregnancies complicated by such risk factors as problems with amniotic fluid levels and maternal blood disorders. Early, comprehensive, and risk-appropriate care to manage such conditions has contributed to reductions in fetal mortality rates. 
Short gestation and LBW are among the leading causes of neonatal death, accounting for 20 percent of neonatal deaths. In 1998, a total of 11.6 percent of births were preterm, and 7.6 percent were LBW. Included in these statistics were VLBW infants weighing less than 1,500 grams (3.3 pounds). The rate of VLBW births was 1.4 percent in 1998. The VLBW rate has increased slightly since 1990 among whites and other population groups including African Americans, Puerto Ricans, and American Indians.1
LBW is associated with long-term disabilities, such as cerebral palsy, autism, mental retardation, vision and hearing impairments, and other developmental disabilities. (See Focus Area 6. Disability and Secondary Conditions and Focus Area 28. Vision and Hearing.) Despite the low proportion of pregnancies resulting in LBW babies, expenditures for the care of LBW infants total more than half of the costs incurred for all newborns. In 1988, the cost of a normal, healthy delivery averaged $1,900, whereas hospital costs for LBW infants averaged $6,200. 
The general category of LBW infants includes both those born too early (preterm infants) and those who are born at full term but who are too small, a condition known as intrauterine growth retardation (IUGR). Maternal characteristics that are risk factors associated with IUGR include maternal LBW, prior LBW birth history, low prepregnancy weight, cigarette smoking, multiple births, and low pregnancy weight gain. Cigarette smoking is the greatest known risk factor.
VLBW usually is associated with preterm birth. Relatively little is known about risk factors for preterm birth, but the primary risk factors are prior preterm birth and spontaneous abortion, low prepregnancy weight, and cigarette smoking.6 These risk factors account for only one-third of all preterm births. 
The use of alcohol, tobacco, and illegal substances during pregnancy is a major risk factor for LBW and other poor infant outcomes. Alcohol use is linked to fetal death, LBW, growth abnormalities, mental retardation, and fetal alcohol syndrome (FAS). Overall rates of alcohol use during pregnancy have increased during the 1990s, and the proportion of pregnant women using alcohol at higher and more hazardous levels has increased substantially. Smoking during pregnancy is linked to LBW, preterm delivery, SIDS, and respiratory problems in newborns. In addition to the human cost of these conditions, the economic cost of services to substance-exposed infants is great: health expenditures related to FAS are estimated to be from $75 million to $9.7 billion each year.7 Over $500 million a year is spent on medical expenses for infants exposed to cocaine in utero. Smoking-attributable costs of complicated births in 1995 were estimated at $1.4 billion (11 percent of costs for all complicated births, based on smoking prevalence during pregnancy of 19 percent) and $2.0 billion (15 percent for all complicated births, based on smoking prevalence during pregnancy of 27 percent).
Finally, breastfeeding is an important contributor to overall infant health because human breast milk presents the most complete form of nutrition for infants; therefore, the American Academy of Pediatrics recommends that infants be breastfed for approximately the first 6 months of life. (The American Academy of Pediatrics recommends that women who test positive for human immunodeficiency virus (HIV) not breastfeed to help prevent transmission of the virus to their infants.) Breastfeeding rates have increased over the years, particularly in early infancy. However, breastfeeding rates among women of all races decrease substantially by 5 to 6 months postpartum. The 1998 rates at 5 to 6 months were only 31 percent among white women, 19 percent among African American women, and 28 percent among Hispanic women.
Also important to child health are the prevention and treatment of disabilities in children. Twelve percent of all children under age 18 years have a disability (defined as a limitation in one or more functional areas). In 1994, 10.6 percent of all children aged 5 to 17 years had limitations in learning ability, 6 percent had limitations in communication, 1.3 percent had limitations in mobility, and 0.9 percent had limitations in personal care. The burden of childhood disability is compounded because affected children live with their disabling conditions many more years than do persons acquiring disability later in life. In 1992, asthma and mental retardation were the most common disabling conditions, accounting for 40 percent of all activity limitations. Other major disabling conditions in childhood include speech impairment, hearing impairment, cerebral palsy, epilepsy, and leg impairment. (See Focus Area 6. Disability and Secondary Conditions and Focus Area 28. Vision and Hearing.)
The objectives in this focus area cover the broad array of childhood conditions and genetic disorders. Examples of preventable birth defects are spina bifida and other neural tube defects (NTDs). The occurrence of these disorders could be reduced by more than half if women consumed adequate folic acid before and during pregnancy.
All States require newborns to be screened for genetic conditions, such as phenylketonuria (PKU) and hypothyroidism; the majority of States also require screening for sickle cell disease. Although not necessarily preventable, these conditions are susceptible to intervention after delivery. For example, nutritional interventions in infancy can prevent mental retardation in children with PKU, penicillin can prevent infection in children with sickle cell disease, and hormone replacement can prevent mental retardation in children with hypothyroidism. Thus, adequate screening of newborns is the first step toward prevention of illness, disability, and death.
In addition to infant deaths and health conditions, the effect of pregnancy and childbirth on women is an important indicator of women’s health. In 1997, a total of 327 maternal deaths were reported by vital statistics. While this number is small, maternal death remains significant because a high proportion of these deaths are preventable and because of the impact of women’s premature death on families. The maternal mortality ratio among African American women consistently has been three to four times that of white women. Ectopic pregnancy is an important cause of pregnancy-related illness and disability in the United States and the leading cause of maternal death in the first trimester. The risk of ectopic pregnancy increases with age; women of all races aged 35 to 44 years are at more than three times the risk of ectopic pregnancy than are women aged 15 to 24 years. Preeclampsia and eclampsia also are important causes of maternal death. Other causes of maternal death are hemorrhage, embolism, infection, and anesthesia-related complications.
The rates of many of these indicators have shown improvement over the past decade. The rate of infant mortality declined more than 27 percent between 1987 and 1997. The rate of fetal mortality declined 8 percent between 1987 and 1995.1 Other indicators show less progress. The LBW rate increased 10 percent between 1987 and 1998.1 The rate of FAS has risen steeply, especially among African Americans. In addition, the maternal mortality rate has not declined since 1982, nor has the disparity between African American and white women.2, 
Despite these unfavorable trends, evidence is encouraging about increases in women’s use of health practices that can help their own health and that of their infants. The percentage of pregnant women who start prenatal care early increased 9.2 percent between 1987 and 1998. The percentage of mothers who breastfeed their newborns also went up 18.5 percent between 1988 and 1998, with greater gains among African American and Hispanic women. Other maternal health practices have shown less improvement: in 1992–94, the proportion of women of childbearing age reporting consumption of the recommended level of folic acid (400 micrograms) was 21 percent.
Disparities
Many of these conditions and risk factors disproportionately affect certain racial and ethnic groups. The disparities between white and nonwhite groups in infant death, maternal death, and LBW are wide and, in many cases, are growing. Specifically:
•	The 1997 infant mortality rate among African American infants was 2.3 times that of white infants. Although infant mortality rates have declined within both racial groups, the proportional discrepancy between African Americans and whites remains largely unchanged.16 
•	The rate of maternal mortality among African Americans is 20.3 per 100,000 live births, nearly four times the white rate of 5.1 per 100,000. African American women continue to be three to four times more likely than white women to die of pregnancy and its complications. The maternal death differential between African Americans and whites is highest for pregnancies that did not end in live birth (ectopic pregnancy, spontaneous and induced abortions, and gestational trophoblastic disease).19
•	Rates of LBW for white women have risen from 5.7 percent of births in 1990 to 6.5 percent in 1998. Among African Americans, the LBW rate has declined slightly in the 1990s but remains twice as high as that of whites—13 percent in 1998. African Americans also are more likely to have other risk factors, such as young maternal age, high birth order (that is, having many live births), less education, and inadequate prenatal care. Puerto Ricans also are especially likely to have LBW infants.4
•	American Indians or Alaska Natives and African Americans account for a disproportionate share of FAS deaths. In 1990, the rates of FAS among American Indians or Alaska Natives and African Americans were 5.2 and 1.4 per 1,000 live births, respectively, compared with 0.4 per 1,000 among the population as a whole.18

African American and Hispanic women also are less likely than whites to enter prenatal care early. For both African American and white women, the proportion entering prenatal care in the first trimester rises with maternal age until the late thirties, then begins to decline. For example, in 1998, 57 percent of African American women under age 18 years began care early, compared with 66 percent of white women of the same age. Among women aged 18 to 24 years, 68 percent of African Americans received care in their first trimester, compared to 76 percent of white women. Among women aged 25 to 39 years, 79 percent of African American women entered care early, compared with 89 percent of white women.4
Women in certain racial and ethnic groups also are less likely than white women to breastfeed their infants. In the early postpartum period, 45 percent of African American mothers and 66 percent of Hispanic mothers breastfed in 1998, compared with 68 percent of white women. These differences persist at 5 to 6 months postpartum, when 19 percent of African American women, 28 percent of Hispanic women, and 31 percent of white women breastfed.12
Opportunities
Many of the risk factors mentioned can be mitigated or prevented with good preconception and prenatal care. First, preconception screening and counseling offer an opportunity to identify and mitigate maternal risk factors before pregnancy begins. Examples include daily folic acid consumption (a protective factor) and alcohol use (a risk factor). During preconceptional counseling, healthcare providers also can refer women for medical and psychosocial or support services for any risk factors identified. Counseling needs to be culturally appropriate and linguistically competent. Prenatal visits offer an opportunity to provide information about the adverse effects of substance use, including alcohol and tobacco during pregnancy, and serve as a vehicle for referrals to treatment services. The use of timely, high-quality prenatal care can help to prevent poor birth outcomes and improve maternal health by identifying women who are at particularly high risk and taking steps to mitigate risks, such as the risk of high blood pressure or other maternal complications. Interventions targeted at prevention and cessation of substance use during pregnancy may be helpful in further reducing the rate of preterm delivery and low birth weight., ,  Further promotion of folic acid intake can help to reduce the rate of NTDs., 
Other actions taken after birth can significantly improve infants’ health and chances of survival. Breastfeeding has been shown to reduce rates of infection in infants and to improve long-term maternal health., , , , , , , , , , , , ,  SIDS may be preventable as well; studies show that putting infants to sleep on their backs can help to prevent SIDS.
Interim Progress Toward Year 2000 Objectives
Of the 17 maternal and infant health objectives included in Healthy People 2000, progress has been made toward the target in 8 objectives, and movement has been away from the target in 5 objectives. Notable gains have been made in the areas of infant death, fetal death, cesarean birth (particularly repeat cesareans), breastfeeding, early use of prenatal care, hospitalization for complications of pregnancy, abstinence from tobacco use during pregnancy, and screening for fetal abnormalities and genetic disorders. However, no progress or movement in the wrong direction has occurred in the areas of maternal death, FAS, and LBW. For the other objectives, progress has been mixed, or data remain unavailable. Child health objectives were not included in the Maternal and Infant focus area in Healthy People 2000.
Note: Unless otherwise noted, data are from the Centers for Disease Control and 
Prevention, National Center for Health Statistics, Healthy People 2000 Review, 1998–99.

Healthy People 2010—Summary of Objectives
Goal: Improve the health and well-being of women, infants, children, 
and families.
		
Number	Objective Short Title	
Fetal, Infant, Child, and Adolescent Deaths	
16-1	Fetal and infant deaths	
16-2	Child deaths	
16-3	Adolescent and young adult deaths	
Maternal Deaths and Illnesses	
16-4	Maternal deaths	
16-5	Maternal illness and complications due to pregnancy	
Prenatal Care	
16-6	Prenatal care	
16-7	Childbirth classes	
Obstetrical Care	
16-8	Very low birth weight infants born at level III hospitals	
16-9	Cesarean births	
Risk Factors	
16-10	Low birth weight and very low birth weight	
16-11	Preterm births	
16-12	Weight gain during pregnancy	
16-13	Infants put to sleep on their backs	
Developmental Disabilities and Neural Tube Defects	
16-14	Developmental disabilities	
16-15	Spina bifida and other neural tube defects	
16-16	Optimum folic acid levels	
Prenatal Substance Exposure	
16-17	Prenatal substance exposure	
16-18	Fetal alcohol syndrome	

Breastfeeding, Newborn Screening, and Service Systems	
16-19	Breastfeeding	
16-20	Newborn bloodspot screening	
16-21	Sepsis among children with sickle cell disease	
16-22	Medical homes for children with special health care needs	
16-23	Service systems for children with special health care needs	

Healthy People 2010 Objectives
Fetal, Infant, Child, and Adolescent Deaths
16-1.	Reduce fetal and infant deaths.
Target and baseline:
Objective	Reduction in Fetal and Infant Deaths	1997 Baseline	2010 Target	
		Per 1,000 Live Births Plus Fetal Deaths	
16-1a.	Fetal deaths at 20 or more weeks of 
gestation	6.8	4.1	
16-1b.	Fetal and infant deaths during perinatal period (28 weeks of gestation to 7 days or more after birth)	7.5	4.5	

Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.
Live Births Plus Fetal Deaths, 1997	16-1a.
Fetal Deaths at 20 or More Weeks of 
Gestation	16-1b.
Fetal and Infant Deaths During 
Perinatal Period	
	Rate per 1,000	
TOTAL	6.8	7.5	
Mother’s race and ethnicity	
American Indian or Alaska Native	6.7	7.9	
Asian or Pacific Islander	4.8	4.6	
Asian	4.2	4.6	
Native Hawaiian and other
Pacific Islander	6.2	7.3	
Black or African American	12.5	13.4	
White	5.8	6.4	
	
Hispanic or Latino	5.9	6.5	
Not Hispanic or Latino	DNA	7.2	
Black or African American	9.6	12.7	
White	5.2	6.0	
Gender	
Female	DNA	DNA	
Male	DNA	DNA	
Mother’s education level	
Less than high school	6.5	DNA	
High school graduate	6.7	DNA	
At least some college	4.8	DNA	
Mother’s disability status	
Mothers with disabilities	DNC	DNC	
Mothers without disabilities	DNC	DNC	
Select populations	
Mother’s age groups	
Under 15 years 	14.2	DNA	
15 to 19 years 	7.8	DNA	
20 to 24 years 	6.4	DNA	
25 to 29 years 	6.0	DNA	
30 to 34 years 	6.3	DNA	
35 years and older	8.9	DNA	
Fetal weight	
>2,499 g	1.3	DNA	
1,500 to 2,499 g	16.8	DNA	
<1,500 g	213.1	DNA	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

Target and baseline:
Objective	Reduction in Infant Deaths	1998 Baseline	2010 Target	
		Rate per 1,000 Live Births	
16-1c.	All infant deaths (within 1 year)	7.2	4.5	
16-1d.	Neonatal deaths (within the first 28 days of life)	4.8	2.9	
16-1e.	Postneonatal deaths (between 28 days and 1 year)	2.4	1.2	

Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.
Live Births, 1998	16-1c.
All Infant Deaths
(<1 year)	16-1d. 
Neonatal Deaths
(<28 days)	16-1e. 
Postneonatal Deaths
(28 to 364 days)	
	Rate per 1,000	
TOTAL	7.2	4.8	2.4	
Mother’s race and ethnicity	
American Indian or Alaska
Native	9.3	5.0	4.3	
Asian or Pacific Islander	5.5	3.9	1.7	
Asian	5.0	3.6	1.3	
Native Hawaiian and other Pacific Islander	10.0	6.7	3.3	
Black or African American	13.8	9.4	4.4	
White	6.0	4.0	2.0	
	
Hispanic or Latino	5.8	3.9	1.9	
Not Hispanic or Latino	7.5	5.0	2.5	
Black or African American	13.9	9.4	4.5	
White	6.0	3.9	2.0	
Gender	
Female	6.5	4.4	2.2	
Male	7.8	5.2	2.6	
Mother’s education level	
Less than high school	9.1	5.2	3.8	
High school graduate	7.7	5.1	2.6	
At least some college	5.3	3.8	1.5	
Mother’s disability status	
Mothers with disabilities	DNC	DNC	DNC	
Mothers without disabilities	DNC	DNC	DNC	
Select populations	
Mother’s age groups	
Under 15 years 	18.4	12.6	5.8	
15 to 19 years 	10.0	6.1	3.9	
20 to 24 years 	7.8	4.8	3.0	
25 to 29 years 	6.3	4.3	2.0	
30 to 34 years 	6.0	4.4	1.6	
35 years and older	7.1	5.2	1.9	
Fetal weight	
>2,499 g	2.6	0.9	1.7	
1,500 to 2,499 g	16.5	9.6	6.8	
<1,500 g	250.0	221.5	28.5	

DNA = Data have not been analyzed.  DNC = Data are not collected.  DSU = Data are statistically unreliable.

Target and baseline:
Objective	Reduction in Infant Deaths 
Related to Birth Defects	1998 
Baseline	2010 
Target	
		Rate per 1,000 Live Births	
16-1f.	All birth defects	1.6	1.1	
16-1g.	Congenital heart defects	0.53	0.38	

Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.

Live Births, 1998 (unless noted)	16-1f.
All Infant Deaths From All Birth 
Defects	16-1g.
All Infant Deaths From Congenital Heart Defects	
	Rate per 1,000	
TOTAL	1.6	0.53	
Mother’s race and ethnicity	
American Indian or Alaska Native	1.7	0.67	
Asian or Pacific Islander	1.5	0.50	
Asian	1.5	0.48	
Native Hawaiian and other Pacific Islander	DSU	DSU	
Black or African American	1.8	0.60	
White	1.5	0.51	
	
Hispanic or Latino	1.5	0.47	
Not Hispanic or Latino	1.6	0.54	
Black or African American	1.8	0.61	
White	1.5	0.53	
Gender	
Female 	1.6 (1995)	DNA	
Male 	1.8 (1995)	DNA	
Mother’s education level	
Less than high school	1.8	0.58	
High school graduate	1.6	0.58	
At least some college	1.4	0.45	
Disability status (of infant)	
Persons with disabilities	DNC	DNC	
Persons without disabilities	DNC	DNC	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

16-1h. Reduce deaths from sudden infant death syndrome (SIDS).
Target: 0.25 deaths per 1,000 live births. 
Baseline: 0.72 deaths per 1,000 live births were from SIDS in 1998.
Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.

Live Births, 1998	16-1h.
SIDS Deaths	
	Rate per 1,000	
TOTAL	0.72	
Mother’s race and ethnicity	
American Indian or Alaska Native	1.52	
Asian or Pacific Islander	0.39	
Asian	0.27	
Native Hawaiian and other Pacific Islander	DSU	
Black or African American	1.38	
White	0.60	
	
Hispanic or Latino	0.37	
Not Hispanic or Latino	0.80	
Black or African American	1.40	
White	0.66	
Gender	
Female	DNA	
Male	DNA	
Mother’s education level	
Less than high school	1.30	
High school graduate	0.79	
At least some college	0.38	
Disability status (of infant)	
Persons with disabilities	DNC	
Persons without disabilities	DNC	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

Infant death is a critical indicator of the health of a population. It reflects the overall state of maternal health as well as the quality and accessibility of primary health care available to pregnant women and infants. Despite steady declines in the 1980s and 1990s, the rate of infant mortality in the United States remains among the highest in the industrialized world.1 Moreover, the rate of decline in infant mortality has slowed since the 1970s, when major advances in neonatal care contributed to steep reductions in the neonatal mortality rate. However, the rapid decline in this rate slowed during the 1980s. In the early 1990s, the introduction of synthetic surfactant contributed to declines in neonatal mortality rates through decreased new cases of intraventricular hemorrhage and decreased severity of respiratory disease in preterm, very small infants., 
The health of infants depends in large part on their health in utero. A fetus with severe defects or growth problems may not be delivered alive. Because only live births are counted in infant mortality rates, perinatal and fetal mortality rates provide a more complete picture of perinatal health than does the infant mortality rate alone.
Fetal death often is associated with maternal complications of pregnancy, such as problems with amniotic fluid levels and blood disorders. Rates of fetal mortality are 35 percent greater than average in women who use tobacco during pregnancy and 77 percent higher in women who use alcohol.3 Fetal mortality rates also are high when birth defects, such as anencephalus, renal agenesis, and hydrocephalus, are present.3 The baseline fetal mortality rate of 6.8 per 1,000 represents only a 6.7 percent reduction since 1990, an average rate of decline of 1.3 percent per year. The fetal mortality rate among African Americans was 12.7 per 1,000 in 1995, 1.8 times that of the population as a whole. Moreover, this gap has widened since 1990. The rate among African Americans declined by only 4.5 percent over this period, a decline of less than 1 percent per year.3 Targeting prenatal risk screening and intervention to high-risk groups, particularly African American women, is critical to reducing this gap. 
The perinatal mortality rate includes both deaths of live-born infants through the first 7 days of life and fetal deaths after 28 weeks of gestation. This rate is a useful overall measure of perinatal health and the quality of health care provided to pregnant women and newborns. The rate of perinatal mortality has declined by 40 percent since 1980.1 The gap between African Americans and whites has increased, however, with the rate among African Americans now more than twice that of whites.1
The infant mortality rate is made up of two components: neonatal mortality (death in the first 28 days of life) and postneonatal mortality (death from the infants’ 29th day but within the first year). The leading causes of neonatal death include birth defects, disorders related to short gestation and LBW, and pregnancy complications. Of these, the most likely to be preventable are those related to preterm birth and LBW, which represent approximately 20 percent of neonatal deaths. Postneonatal death reflects events experienced in infancy, including SIDS, birth defects, injuries, and homicide. Birth defects, many of which are unlikely to be preventable given current scientific knowledge, account for approximately 17 percent of postneonatal deaths; the remainder are likely to stem from preventable causes.
SIDS is the leading cause of postneonatal death among all racial and ethnic groups, representing nearly one-third of all cases of postneonatal death. Moreover, the rate of SIDS among African Americans is 1.4 per 1,000 live births, twice that of whites. Therefore, a reduction in the rate of death from SIDS, particularly among African Americans, would contribute greatly to reducing the overall infant mortality rate and particularly to closing the racial gap in postneonatal death. The 2010 target should be achievable with continued education. (See objective 16-13 for further discussion of interventions that can help to prevent SIDS).
Rates of death from birth defects can be reduced either by preventing the occurrence of the defect itself or by providing the necessary care to prevent death. In the case of NTDs, the birth defects themselves can be prevented (see objectives 16-17 and 16-18). Death from birth defects that are not so easily prevented, such as heart problems, can be reduced with access to appropriate medical care. (Respiratory distress syndrome, another leading cause of infant death, is not a birth defect but a consequence of prematurity.) 
A particular issue in the reduction of infant death is the reduction of disparities among select populations, particularly as defined by race and ethnicity, maternal age, and infant birth weight. The gap between whites and African Americans in infant death is large and has not diminished since 1990. 
16-2.	Reduce the rate of child deaths.
Target and baseline:
Objective	Reduction in Deaths of Children	1998 Baseline	2010 Target	
		Rate per 100,000	
16-2a.	Children aged 1 to 4 years	34.6	18.6	
16-2b.	Children aged 5 to 9 years	17.7	12.3	

Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.

Children, 1998	16-2a.
Deaths of 
Children Aged 
1 to 4 Years	16-2b.
Deaths of 
Children Aged 
5 to 9 Years	
	Rate per 100,000	
TOTAL	34.6	17.7	
Race and ethnicity	
American Indian or Alaska Native	59.2	22.3	
Asian or Pacific Islander	18.7	12.4	
Asian	DNC	DNC	
Native Hawaiian and other Pacific Islander	DNC	DNC	
Black or African American	61.6	29.0	
White	30.1	15.7	
	
Hispanic or Latino	30.4	15.7	
Not Hispanic or Latino	35.3	18.0	
Black or African American	64.7	30.6	
White	29.4	15.3	
Gender	
Female	31.4	15.3	
Male	37.6	20.0	
Family income level	
Poor	DNC	DNC	
Near poor	DNC	DNC	
Middle/high income	DNC	DNC	
Disability status 	
Persons with disabilities	DNC	DNC	
Persons without disabilities	DNC	DNC	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

The deaths of children after infancy also present a public health concern and an opportunity for prevention. In 1997, 13,562 children aged 1 to 14 years died, representing a death rate of 25.1 per 100,000 children in that age group. The leading cause of death for children of all ages is injury, which accounts for 13.1 deaths per 100,000 preschool children (aged 1 to 4 years) and 8.7 deaths per 100,000 school-aged children (aged 5 to 14 years). Among children aged 1 to 4 years, the leading injury-related causes of death are motor vehicle crashes, drownings, and fires and burns. Among those aged 5 to 14 years, the leading causes of death include motor vehicle crashes and firearms (including unintentional deaths, homicides, and suicides). These deaths are, for the most part, preventable. Other leading causes of death among children that are less likely to be preventable include birth defects (representing 3.8 deaths per 100,000 children aged 1 to 4 years and 1.2 deaths per 100,000 children aged 5 to 14 years), malignant neoplasms (representing 2.9 deaths per 100,000 children aged 1 to 4 years and 2.7 deaths per 100,000 children aged 5 to 14 years), and diseases of the heart (representing 1.4 deaths per 100,000 children aged 1 to 4 years and 0.8 deaths per 100,000 children aged 5 to 14 years).16 

16-3.	Reduce deaths of adolescents and young adults.
Target and baseline:
Objective	Reduction in Deaths of 
Adolescents and Young Adults	1998 
Baseline	2010 
Target	
		Rate per 100,000	
16-3a.	Adolescents aged 10 to 14 years	22.1	16.8	
16-3b.	Adolescents aged 15 to 19 years	70.6	39.8	
16-3c.	Young adults aged 20 to 24 years	95.3	49.0	
Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.
Adolescents and Young Adults, 1998	16-3a.
Deaths of Adolescents Aged 10 to 14 Years	16-3b.
Deaths of Adolescents Aged 15 to 19 Years	16-3c.
Deaths of Young Adults Aged 20 to 24 Years	
	Rate per 100,000	
TOTAL	22.1	70.6	95.3	
Race and ethnicity	
American Indian or Alaska Native	26.7	90.5	146.1	
Asian or Pacific Islander	17.9	39.9	49.1	
Asian	DNC	DNC	DNC	
Native Hawaiian and other 
Pacific Islander	DNC	DNC	DNC	
Black or African American	29.9	97.2	160.3	
White	20.8	66.6	84.9	
	
Hispanic or Latino	19.1	67.6	99.6	
Not Hispanic or Latino	22.6 	70.7	94.0	
Black or African American	31.3	100.8	165.8	
White	20.8	65.3	80.2	
Gender	
Female	17.2	40.8	46.5	
Male	26.9	98.7	142.3	
Family income level	
Poor	DNC	DNC	DNC	
Near poor	DNC	DNC	DNC	
Middle/high income	DNC	DNC	DNC	
Disability status	
Persons with disabilities	DNC	DNC	DNC	
Persons without disabilities	DNC	DNC	DNC	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

The deaths of young adolescents, older adolescents, and young adults are more likely to be due to external causes than to congenital diseases. There were 4,261 deaths among adolescents aged 10 to 14 years in 1998, for a mortality rate of 22.1 per 100,000. The leading cause of death for adolescents in this age group was motor vehicle crashes at 5.4 deaths per 100,000 or 24.3 percent of the total mortality. Other unintentional injuries (such as falls, drownings, and poisonings) caused 3.5 deaths per 100,000 (15.9 percent); homicides caused 1.5 deaths per 100,000 (6.8 percent); suicides caused 1.6 deaths per 100,000 (7.4 percent); and AIDS caused 0.1 deaths per 100,000 (0.6 percent). Fifty-five percent of the total deaths in this age group, therefore, can be attributed to unnecessary (that is, preventable) causes. Other causes of death for this age group that are less amenable to prevention strategies given current scientific knowledge include malignant neoplasms, which caused 2.7 deaths per 100,000 (12.3 percent); birth defects, which caused 0.9 deaths per 100,000 (4.1 percent); diseases of the heart, which caused 0.9 deaths per 100,000 (4.0 percent); and a combination of other causes, which caused 5.5 deaths per 100,000 (25 percent).16, 
There were 13,788 deaths in 1998 among adolescents aged 15 to 19 years, for a death rate of 70.6 per 100,000. The leading cause of death for adolescents in this age group was motor vehicle crashes at 28.4 deaths per 100,000 or 37.4 percent of total deaths. Other unintentional injuries (such as falls, drownings, and poisonings) caused 7.3 deaths per 100,000 (10.4 percent); homicides caused 11.8 deaths per 100,000 (16.8 percent); suicides caused 8.9 deaths per 100,000 (12.6 percent); and AIDS caused 0.1 deaths per 100,000 (0.2 percent). Consequently, a majority (77 percent) of the total deaths in this age group can be attributed to unnecessary (that is, preventable) causes. The remaining 23 percent of deaths among adolescents aged 15 to 19 years resulted mostly from malignant neoplasms, which caused 3.7 deaths per 100,000 (5.2 percent); diseases of the heart, which caused 2.1 deaths per 100,000 (3.0 percent); birth defects, which caused 1.1 deaths per 100,000 (1.6 percent); and a combination of other causes, which caused 9.1 deaths per 100,000 (12.9 percent).
Young adults aged 20 to 24 years had a death rate of 95.3 per 100,000 in 1998—a rate 331 percent higher than adolescents aged 10 to 14 years and 35 percent higher than adolescents aged 15 to 19 years. The leading cause of death for persons aged 20 to 24 years was motor vehicle crashes at 27.5 deaths per 100,000 or 28.9 percent of the total deaths. Other unintentional injuries (such as falls, drownings, and poisonings) caused 10.7 deaths per 100,000 (11.2 percent); homicides caused 18.1 deaths per 100,000 (19 percent); suicides caused 13.6 deaths per 100,000 (14.2 percent); and AIDS caused 1.0 deaths per 100,000 (1.4 percent). Consequently, a majority (74 percent) of the total deaths in this age group can be attributed to unnecessary (that is, preventable) causes. The remaining 26 percent of deaths among young adults aged 20 to 24 years resulted mostly from malignant neoplasms, which caused 5.5 deaths per 100,000 (5.8 percent); diseases of the heart, which caused 3.6 deaths per 100,000 (3.8 percent); birth defects, which caused 1.3 deaths per 100,000 (1.4 percent); and a combination of other causes, which caused 13.9 deaths per 100,000 (14.6 percent).
The data on deaths, however, do not adequately reflect consequences of sexual behaviors established as individuals in this age group become sexually mature. Illustratively, it is likely that most of the new HIV infections that are diagnosed each year occur among those between age 13 and 21 years. Further, about 3 million new and sexually transmitted disease infections (STDs) in addition to HIV occur among teenagers each year. In addition, about 1 million teenagers become pregnant each year. (See Focus Area 13. HIV and Focus Area 25. Sexually Transmitted Diseases.)
Maternal Deaths and Illnesses
16-4.	Reduce maternal deaths.
Target: 3.3 maternal deaths per 100,000 live births.
Baseline: 7.1 maternal deaths per 100,000 live births occurred in 1998.
Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.
Live Births, 1998	Maternal Deaths	
	Rate per 100,000	
TOTAL	7.1	
Mother’s race and ethnicity	
American Indian or Alaska Native	DSU	
Asian or Pacific Islander	DSU	
Asian	DSU	
Native Hawaiian and other Pacific Islander	DSU	
Black or African American	17.1	
White	5.1	
	
Hispanic or Latino	5.7	
Not Hispanic or Latino	7.5	
Black or African American	17.4	
White	4.9	
Mother’s education level	
Less than high school	DNA	
High school graduate	DNA	
At least some college	DNA	
Mother’s disability status	
Mothers with disabilities	DNC	
Mothers without disabilities	DNC	
Select populations	
Mother’s age groups	
Under 20 years 	DSU	
20 to 24 years 	5.0	
25 to 29 years 	6.7	
30 to 34 years 	7.5	
35 years and older	14.5	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.
16-5.	Reduce maternal illness and complications due to 
pregnancy.
Target and baseline:
Objective	Reduction in Maternal Illness and Complications	1998
Baseline	2010 
Target	
		Per 100 Deliveries	
16-5a.	Maternal complications during 
hospitalized labor and delivery	31.2	24	
16-5b.	Ectopic pregnancies	Developmental	
16-5c.	Postpartum complications, including postpartum depression	Developmental	

Target setting method: Better than the best.

Data source: National Hospital Discharge Survey, CDC, NCHS.
Potential data source: National Hospital Discharge Survey (NHDS), CDC, NCHS.
Deliveries, 1998	16-5a.
Maternal 
Complications 
During 
Hospitalized Labor and Delivery	
	Rate per 100 
Deliveries	
TOTAL	31.2	
Race and ethnicity	
American Indian or Alaska Native	DSU	
Asian or Pacific Islander	DSU	
Asian	DNC	
Native Hawaiian and other Pacific Islander	DNC	
Black or African American	37.7	
White	30.3	
	
Hispanic or Latino	DSU	
Not Hispanic or Latino	DSU	
Black or African American	DSU	
White	DSU	
Family income level	
Poor	DNC	
Near poor	DNC	
Middle/high income	DNC	
Select populations	
Mother’s age group	
Under 15 years 	DSU	
15 to 19 years 	34.4	
20 to 24 years 	30.4	
25 to 29 years 	29.7	
30 to 34 years	31.1	
35 years and older	32.7	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

In 1997, 327 maternal deaths were reported by vital statistics, the major causes of which were hemorrhage, ectopic pregnancy, pregnancy-induced hypertension, embolism, infection, and other complications of pregnancy and childbirth. The overall maternal mortality rate has fluctuated between approximately 7 and 8 per 100,000 live births since 1982. Moreover, the gap between African Americans and whites remains, with the maternal mortality rate among African Americans 3.6 times that of whites in 1997. The rates among African Americans have been at least three to four times higher than those of whites since 1940. The rate among African Americans also has not declined, fluctuating between about 18 and 22 per 100,000 live births.44 
Pregnancy and delivery can lead to serious physical and mental health problems for women. In the past, maternal illness and complications were monitored through objectives relating to the ratio of antenatal hospitalizations for pregnancy complications to the total number of deliveries. This ratio has become a less useful measure, however, as rates of antenatal hospitalization in general have declined due to managed care and its emphasis on outpatient treatment. Therefore, attention should be focused on the major causes of maternal illness and complications, particularly those most likely to be associated with maternal death, such as ectopic pregnancy. Pelvic inflammatory disease caused by chlamydia and gonorrhea is the leading cause of preventable tubal scarring that can result in ectopic pregnancy. (See Focus Area 25. Sexually Transmitted Diseases.) The outcomes of interest should include not only prenatal illness and complications and complications during labor and delivery but also postpartum complications. Postpartum depression, for example, is disabling for a new mother and can compromise her ability to care for her infant.
Prenatal Care
16-6.	Increase the proportion of pregnant women who receive early and adequate prenatal care.
Target and baseline:
Objective	Increase in Maternal Prenatal Care	1998 Baseline 	2010 Target	
		Percent of Live Births	
16-6a.	Care beginning in first trimester of pregnancy	83	90	
16-6b.	Early and adequate prenatal care	74	90	

Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.
Live Births, 1998	Maternal Prenatal Care	
	16-6a.
First Trimester	16-6b.
Early and
Adequate 	
	Percent	
TOTAL	83	74	
Mother’s race and ethnicity	
American Indian or Alaska Native	69	57	
Asian or Pacific Islander	83	74	
Asian	86	76	
Native Hawaiian and other Pacific Islander	75	67	
Black or African American	73	67	
White	85	76	
	
Hispanic or Latino	74	66	
Not Hispanic or Latino	85	76	
Black or African American	73	67	
White	88	79	
Mother’s education level	
Less than high school	68	61	
High school graduate	81	74	
At least some college	91	82	
Mother’s disability status	
Mothers with disabilities	DNC	DNC	
Mothers without disabilities	DNC	DNC	
Select populations	
Mother’s age groups	
Under 15 years 	48	48	
15 to 19 years 	69	64	
20 to 24 years	78	70	
25 to 29 years	86	77	
30 to 34 years 	89	79	
35 years and older	88	79	
DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.
Prenatal care includes three major components: risk assessment, treatment for medical conditions or risk reduction, and education. Each component can contribute to reductions in perinatal illness, disability, and death by identifying and mitigating potential risks and helping women to address behavioral factors, such as smoking and alcohol use, that contribute to poor outcomes. Prenatal care is more likely to be effective if women begin receiving care early in pregnancy. Since 1990, the proportion of infants whose mothers entered prenatal care in the first trimester increased 8.8 percent, from 76 percent to 83 percent. Among African Americans, this proportion grew 19 percent and among Hispanics, 22 percent.1 Thus, increases in early entry into prenatal care have been concentrated in those populations whose perinatal illness and disability rates and mortality rates are highest and who are most likely to have low incomes. These increases are likely due, in part, to increased access to Medicaid coverage for pregnancy-related services and improved outreach by Medicaid programs. In addition, the likelihood of early entry into prenatal care rises with age. The risk of poor birth outcomes is greatest among the youngest mothers (aged 15 years and under). Clearly, therefore, continued work is needed to educate women, particularly young women, about the need to begin prenatal care early in pregnancy.
Prenatal care should begin early and continue throughout pregnancy, according to accepted standards of periodicity. For example, the American College of Obstetricians and Gynecologists recommends that women receive at least 13 prenatal visits during a full-term pregnancy. Therefore, assessment of the adequacy of the care pregnant women receive must include monitoring not only the month of initiation of prenatal care but also the adequacy of the care they receive throughout pregnancy. The Adequacy of Prenatal Care Utilization Index (APNCU) measures two dimensions of care: the adequacy of initiation of care and the adequacy of the use of prenatal services once care has begun (by comparing actual use to the recommended number of visits based on the month of initiation of care and the length of the pregnancy). These dimensions are combined to classify each woman’s prenatal care history as inadequate, intermediate, adequate, or adequate-plus. The baseline rates presented above include all women who received either adequate or adequate-plus care.
Overall, nearly three-quarters of women receive adequate prenatal care. However, this proportion varies across racial and ethnic groups. Certain groups, such as American Indians or Alaska Natives and Samoans, are particularly likely to receive less-than-adequate prenatal care. The likelihood of receipt of adequate prenatal care rises with maternal age, with fewer than half of pregnant women aged 15 years and under receiving adequate care.42 Prevention of unwanted pregnancy in adolescents and education of women about the need for early, continuous prenatal care are essential.
16-7.	(Developmental) Increase the proportion of pregnant women who attend a series of prepared childbirth classes. 
Potential data sources: National Pregnancy and Health Survey, NIH, NICHD; National Survey of Family Growth (NSFG) or National Health Interview Survey (NHIS), CDC, NCHS.
As part of comprehensive prenatal care, a formal series of prepared childbirth classes conducted by a certified childbirth educator is recommended for all women by the Expert Panel on the Content of Prenatal Care. These classes can help reduce women’s pain and anxiety as they approach childbirth, making delivery a more pleasant experience and preparing women for what they will face as they give birth. A full series of sessions is recommended for women who have never attended. A refresher series of one or two classes is recommended for women who attended during a previous pregnancy. At a minimum, the childbirth classes should include information regarding the physiology of labor and birth, exercises and self-help techniques for labor, the role of support persons, family roles and adjustments, and preferences for care during labor and birth. The classes also should include an opportunity for the mother and her partner to have questions answered about providers, prenatal care, and other relevant issues, as well as to receive information regarding birth settings and cesarean childbirth. Attendance is recommended during the third trimester of pregnancy so that information learned will be used relatively soon after presentation. Classes should begin at the 31st or 32nd week and be completed no later than 38 weeks. The refresher class should be completed at any time between 36 and 38 weeks.
Obstetrical Care
16-8.	Increase the proportion of very low birth weight (VLBW) infants born at level III hospitals or subspecialty perinatal centers.
Target: 90 percent.
Baseline: 73 percent of VLBW infants were born at level III hospitals or 
subspecialty perinatal centers in 1996–97.
Target setting method: 25 percent improvement. (Better than the best will be used when data are available.)
Data source: Title V Reporting System, HRSA, MCHB.
Data for population groups currently are not analyzed.
Much research has demonstrated the benefits of delivering high-risk infants in settings that have the technological capacity to care for them. Specifically, research has shown that VLBW infants have lower death rates when they are delivered at level III hospitals, which are equipped to care for very small infants., ,  To ensure that high-risk pregnant women have access to appropriate levels of obstetric care, many States have implemented perinatal regionalization strategies and protocols for the transfer of high-risk women to level III facilities. Evidence, however, indicates that these systems may be eroding as health care networks and financing systems change.52,  The proportion of VLBW infants who are delivered in the level III obstetric hospitals best equipped to provide appropriate neonatal care should be measured to monitor the continuing effectiveness of these systems and the appropriateness of the level of care delivered to high-risk pregnant women and infants.
16-9.	Reduce cesarean births among low-risk (full term, 
singleton, vertex presentation) women.
Target and baseline:
Objective	Reduction in Cesarean Births	1998 Baseline	2010 Target	
		Percent of Live Births	
16-9a.	Women giving birth for the first time	18	15	
16-9b.	Prior cesarean birth	72	63	

Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.
Cesarean Births to Low-Risk Women, 1998	Cesarean Birth	
	16-9a.
Women Giving Birth for the First Time	16-9b.
Prior Cesarean Birth	
	Percent	
TOTAL	18	72	
Mother’s race and ethnicity	
American Indian or Alaska Native	16	68	
Asian or Pacific Islander	18	70	
Asian	19	72	
Native Hawaiian and other Pacific Islander	17	65	
Black or African American	21	73	
White	18	72	
	
Hispanic or Latino	18	76	
Not Hispanic or Latino	18	71	
Black or African American	21	73	
White	18	71	
Mother’s education level	
Less than high school	14	72	
High school graduate	18	73	
At least some college	20	71	
Mother’s disability status	
Mothers with disabilities	DNC	DNC	
Mothers without disabilities	DNC	DNC	
Select populations	
Mother’s age groups	
Under 15 years old	13	DSU	
15 to 19 years 	12	67	
20 to 24 years 	16	70	
25 to 29 years 	20	71	
30 to 34 years 	24	72	
35 years and older	32	75	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

During the 1980s, rates of cesarean births rose steadily, with a peak rate of 25 percent of deliveries reported in 1988. Since then, the rate has been slowly decreasing, with the majority of the decline attributable to a reduction in the rates of primary cesarean births. In 1989, the rate of vaginal births among women who had a previous cesarean birth was 19 percent; in 1995 it increased to 28 percent. The improvements are likely to be attributable to use of such strategies as clearer guidelines for trials of labor and labor management, continual labor support, and focused attention on physician practice patterns. Expert opinion called for use of risk-adjusted rates of cesarean births (that is, rates standardized by patient characteristics) to monitor progress over time. (The targets presented here apply to the population as a whole and are not intended to be used as practice outcome objectives for individual physicians or institutions, as the medical needs of the patients in each practice will vary.) In addition to monitoring rates of cesarean births, the outcomes of these deliveries (for both the mother and the infant) should be watched closely to assure that changes in the mode of delivery do not put women or their infants at risk.
Risk Factors
16-10.	Reduce low birth weight (LBW) and very low birth weight (VLBW).
Target and baseline:
Objective	Reduction in Low and Very Low Birth Weight	1998 
Baseline	2010 
Target	
		Percent	
16-10a.	Low birth weight (LBW)	7.6	5.0	
16-10b.	Very low birth weight (VLBW)	1.4	0.9	

Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.
Live Births, 1998 (unless noted)	16-10a.
Low Birth 
Weight	16-10b.
Very Low 
Birth Weight	
	Percent	
TOTAL	7.6	1.4	
Mother’s race and ethnicity	
American Indian or Alaska Native	6.8	1.2	
Asian or Pacific Islander	7.4	1.1	
Asian	7.2	1.1	
Native Hawaiian and other Pacific 
Islander	6.5	1.4	
Black or African American	13.0	3.1	
White	6.5	1.1	
	
Hispanic or Latino	6.4	1.1	
Not Hispanic or Latino	7.8	1.5	
Black or African American	13.2	3.1	
White	6.6	1.1	
Gender	
Female 	8.1 (1997)	1.4 (1997)	
Male 	7.0 (1997)	1.4 (1997)	
Mother’s education level	
Less than high school	9.0	1.6	
High school graduate	7.9	1.5	
At least some college	6.5	1.3	
Mother’s disability status	
Mothers with disabilities	DNC	DNC	
Mothers without disabilities	DNC	DNC	
Select populations	
Mother’s age groups	
Under 15 years	13.1	3.3	
15 to 19 years 	9.5	1.8	
20 to 24 years 	7.5	1.4	
25 to 29 years 	6.7	1.3	
30 to 34 years	7.0	1.4	
35 years and older	8.7	1.7	

DNA = Data have not been analyzed.  DNC = Data are not collected.  DSU = Data are statistically unreliable.

LBW is the risk factor most closely associated with neonatal death; thus, improvements in infant birth weight can contribute substantially to reductions in the infant mortality rate. Of all infants born at low birth weight, the smallest (those weighing less than 1,500 grams) are at highest risk of dying in their first year. However, some researchers have proposed that further improvement in the survival of VLBW infants is nearly impossible, and reduction in the underlying rate of VLBW births is the only avenue toward reduction of neonatal mortality rates. Another important issue is the long-term effects of LBW on affected infants who survive their first year, as these infants are more likely to experience long-term developmental and neurologic disabilities than are infants of normal birth weight.,  Recent increases in LBW are due largely to preterm delivery related to increases in multiple gestation.
Smoking accounts for 20 to 30 percent of all LBW births in the United States. The effect of smoking on LBW rates appears to be attributable to intrauterine growth retardation rather than to preterm delivery.6 VLBW is primarily associated with preterm birth, which may be associated with the use of illicit drugs during pregnancy.

16-11.	Reduce preterm births.
Target and baseline:
Objective	Reduction in Preterm Births	1998 Baseline	2010 Target	
		Percent	
16-11a.	Total preterm births	11.6	7.6	
16-11b.	Live births at 32 to 36 weeks of gestation	9.6	6.4	
16-11c.	Live births at less than 32 weeks of gestation	2.0	1.1	

Target setting method: Better than the best.
Data source: National Vital Statistics System (NVSS), CDC, NCHS.
Live Births, 1998	16-11a.
Total 
Preterm Births	16-11b.
32 to 36 Weeks of Gestation	16-11c.
Less Than 32 Weeks of 
Gestation	
	Percent	
TOTAL	11.6	9.6	2.0	
Mother’s race and ethnicity	
American Indian or Alaska Native	12.2	10.2	2.0	
Asian or Pacific Islander	10.4	8.9	1.4	
Asian	9.7	8.4	1.3	
Native Hawaiian and other Pacific Islander	11.9	9.7	2.0	
Black or African American	17.5	13.4	4.1	
White	10.5	8.9	1.6	
	
Hispanic or Latino	11.4	9.7	1.7	
Not Hispanic or Latino	11.7	9.6	2.0	
Black or African American	17.6	13.4	4.1	
White	10.2	8.7	1.5	
Gender	
Female	DNA	DNA	DNA	
Male	DNA	DNA	DNA	
Mother’s education level	
Less than high school	13.7	11.2	2.4	
High school graduate	12.0	9.9	2.1	
At least some college	10.3	8.7	1.6	
Mother’s disability status	
Mothers with disabilities	DNC	DNC	DNC	
Mothers without disabilities	DNC	DNC	DNC	
Select populations	
Mother’s age groups	
Under 15 years	22.0	16.2	5.8	
15 to 19 years	13.8	11.1	2.7	
20 to 24 years	11.5	9.6	1.9	
25 to 29 years	10.6	8.9	1.7	
30 to 34 years	10.8	9.1	1.8	
35 years and older	12.9	10.8	2.2	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

Approximately two-thirds of LBW infants and 98 percent of VLBW infants are born preterm. In addition, preterm birth is the leading cause of those neonatal deaths not associated with birth defects. Survival rates of infants have been shown to increase as gestational age advances, even among very preterm infants.,  Therefore, reduction in preterm delivery holds the greatest promise for overall reduction in infant illness, disability, and death. Because the specific causes of preterm delivery are unclear, research is needed before tailored interventions can be developed.,  Preterm birth is associated with a number of modifiable risk factors, including the use of alcohol, tobacco, or other drugs during pregnancy,  and low prepregnancy weight or low weight gain during pregnancy.,  Other important risk factors for preterm birth are vaginal infections, ,  and domestic violence.
Rates of preterm delivery in the United States increased over the last three decades of the 20th century.4, 68 Between 1989 and 1996, this increase was due largely to an increase in multiple gestation. The gap between African American and white infants persists as well, for reasons that are largely unexplained and that have been shown to be independent of other known risk factors.66,  Risk factors that African American women may disproportionately experience include short interpregnancy intervals and exposure to psychosocial stress.75, 
16-12.	(Developmental) Increase the proportion of mothers 
who achieve a recommended weight gain during their 
pregnancies.
Potential data source: National Vital Statistics System (NVSS), CDC, NCHS.
Current evidence indicates that gestational weight gain, particularly during the second and third trimesters, is an important determinant of fetal growth. Inadequate weight gain during pregnancy is associated with an increased risk of IUGR, LBW, and infant death., ,  Maternal weight gain is susceptible to intervention and represents an avenue for prevention of poor birth outcomes. The Institute of Medicine’s 1990 guidelines for weight gain in pregnancy recommend a graduated level of weight gain based on a woman’s prepregnancy body mass index (BMI) (that is, the ratio of her weight to her height).78 Under these guidelines, a woman with normal BMI should gain 25 to 35 pounds during pregnancy. Those with below-normal BMI should gain 28 to 40 pounds. Overweight women should gain 15 to 25 pounds.
In 1988, approximately three-quarters of married women who delivered at full term gained the recommended weight during pregnancy.18 Two groups of women who continue to gain less than the recommended level of weight during pregnancy—teenagers and African American women—also are at particularly high risk for having LBW infants and other adverse pregnancy outcomes.
16-13.	Increase the percentage of healthy full-term infants who are put down to sleep on their backs. 
Target: 70 percent.
Baseline: 35 percent of healthy full-term infants were put down to sleep on their backs in 1996.
Target setting method: Better than the best.
Data source: National Infant Sleep Position Study, NIH, NICHD.
Infants, 1996	Put Down 
To Sleep on Their Backs	
	Percent	
TOTAL	35	
Mother’s race and ethnicity	
American Indian or Alaska Native	DNA	
Asian or Pacific Islander	DNA	
Asian	DNC	
Native Hawaiian and other Pacific Islander	DNC	
Black or African American	17	
White	37	
	
Hispanic or Latino	28	
Not Hispanic or Latino	DNA	
Black or African American	DNA	
White	DNA	
Gender	
Female	DNA	
Male	DNA	
Mother’s education level	
Less than high school	DNC	
High school graduate	DNC	
At least some college	DNC	
Mother’s disability status	
Mothers with disabilities	DNC	
Mothers without disabilities	DNC	
Select populations	
Mother’s age groups	
Under 15 years	DNA	
15 to 19 years	DNA	
20 to 24 years	DNA	
25 to 29 years	DNA	
30 to 34 years	DNA	
35 years and older	DNA	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

Much research has shown that a nonprone sleeping position (that is, sleeping on the side or back rather than the stomach) greatly decreases the risk of SIDS among healthy full-term infants.,  However, healthy preterm infants have been shown to be more vulnerable to respiratory problems when put to sleep on their backs. The American Academy of Pediatrics has recommended that healthy full-term infants be put down to sleep on their backs. The National Institute of Child Health and Human Development and the Maternal and Child Health Bureau instituted the “Back to Sleep” campaign in 1994 to educate parents and physicians about this recommendation. While the percentage of infants put to sleep on their stomachs dropped dramatically between 1992 and 1997, much of the improvement was in the percentage of infants put to sleep on their sides. Although not as dangerous as the stomach, from the side position infants may roll onto their stomachs. Therefore, the objective focuses on increasing the percentage of infants who are put down to sleep on their backs.
Developmental Disabilities and Neural Tube Defects
16-14.	Reduce the occurrence of developmental disabilities.
Target and baseline:
Objective	Reduction in Developmental 
Disabilities in Children	1991–94 
Baseline	2010 
Target	
		Rate per 10,000	
16-14a.	Mental retardation	131*	124	
16-14b.	Cerebral palsy	32.2†	31.5	
16-14c.	Autism spectrum disorder	Developmental	
16-14d.	Epilepsy	Developmental	

*Children aged 8 years in metropolitan Atlanta, GA, having an IQ of 70 or less.
†Children aged 8 years in metropolitan Atlanta, GA.

Target setting method: 5 percent improvement.
Data source: Metropolitan Atlanta Developmental Disabilities Surveillance
Program (MADDSP), CDC, NCEH.
Children Aged 8 Years, Atlanta, GA, 1991–94	16-14a.
Mental 
Retardation	16-14b.
Cerebral Palsy	
	Rate per 10,000	
TOTAL	131	32.2	
Race and ethnicity	
American Indian or Alaska Native	DNA	DNA	
Asian or Pacific Islander	DNA	DNA	
Asian	DNC	DNC	
Native Hawaiian and other Pacific Islander	DNC	DNC	
Black or African American	210	38.4	
White	85	30.4	
	
Hispanic or Latino	DNA	DNA	
Not Hispanic or Latino	DNA	DNA	
Black or African American	DNA	DNA	
White	DNA	DNA	
Gender	
Female	107	30.8	
Male	154	35.5	
Family income level	
Poor	DNC	DNC	
Near poor	DNC	DNC	
Middle/high income	DNC	DNC	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

Specific developmental disabilities will be monitored among school-aged children since not all occurrences are manifested or recognized until those ages. A reduction in the rate of LBW, as proposed in objective 16-10, can be expected to result in a lower number of occurrences of most developmental disabilities, because LBW is such a strong risk factor. Interventions to reduce the occurrence of some intrauterine infections (for example, congenital rubella syndrome) and increased access to genetic counseling should reduce prenatal causes of developmental disabilities. The early identification and prophylactic treatment of sickle cell disease are expected to reduce the occurrence of postnatal cerebrovascular complications, which are known postnatal causes of cerebral palsy and mental retardation. Increased safety belt use and other measures to prevent unintentional childhood injury, interventions to prevent child abuse, Haemophilus influenzae immunization, and increased access to medical care to reduce meningitis also will reduce the occurrences of developmental disabilities due to postnatal causes. 
The Metropolitan Atlanta Developmental Disabilities Surveillance Program (MADDSP) is the only high-quality surveillance system that monitors the number of cases of mental retardation and other developmental disabilities. MADDSP is a regional data source from a principally urban area, and therefore MADDSP findings cannot be generalized to the Nation; in particular, MADDSP findings may not be representative of rural regions. Efforts are under way to use MADDSP methods to build similar data systems in other regions of the country.
16-15.	Reduce the occurrence of spina bifida and other neural tube defects (NTDs).
Target: 3 new cases per 10,000 live births.
Baseline: 6 new cases of spina bifida or another NTD per 10,000 live births 
occurred in 1996.
Target setting method: 50 percent improvement. (Better than the best will be used when data are available.)
Data source: National Birth Defects Prevention Network (NBDPN), CDC, NCEH.
Live Births, 1996	New Cases of 
Spina Bifida or 
Other NTDs	
	Rate per 10,000	
TOTAL	6	
Mother’s race and ethnicity	
American Indian or Alaska Native	DNA	
Asian or Pacific Islander	DNA	
Asian	DNC	
Native Hawaiian and other Pacific Islander	DNC	
Black or African American	DNA	
White	DNA	
	
Hispanic or Latino	DNC	
Not Hispanic or Latino	DNC	
Black or African American	DNC	
White	DNC	
Gender	
Female	DNA	
Male	DNA	
Mother’s education level	
Less than high school	DNC	
High school graduate	DNC	
At least some college	DNC	
College graduate	DNC	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.
16-16.	Increase the proportion of pregnancies begun with
an optimum folic acid level.
Target and baseline:
Objective	Increase in Pregnancies Begun 
With Optimum Folic Acid Level	1991–94 
Baseline	2010 
Target	
		Percent	
16-16a.	Consumption of at least 400 μg of folic acid each day from fortified foods or dietary supplements by nonpregnant women aged 15 to 44 years 	21	80	
		Number	
16-16b.	Median RBC folate level among nonpregnant women aged 15 to 44 years	160 ng/ml	220 ng/ml	

Target setting method: Better than the best.
Data source: National Health and Nutrition Examination Survey (NHANES), CDC, NCHS.
Nonpregnant Women Aged 15 to 44 Years, 1991–94	16-16a.
Adequate Folic Acid	16-16b.
Median RBC 
Folate Level	
	Percent	ng/ml	
TOTAL	21	160	
Race and ethnicity	
American Indian or Alaska Native	DSU	DSU	
Asian or Pacific Islander	DSU	DSU	
Asian	DNC	DNC	
Native Hawaiian and other Pacific Islander	DNC	DNC	
Black or African American	17	125	
White	22	169	
	
Hispanic or Latino	DSU	DSU	
Mexican American	13	158	
Not Hispanic or Latino	22	159	
Black or African American	18	123	
White	23	170	
Education level	
Less than high school	12	145	
High school graduate	19	148	
At least some college	28	179	
Disability status	
Persons with disabilities	20	169	
Persons without disabilities	23	159	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

NTDs, including spina bifida, occur when the fetal neural tube fails to close fully, interrupting development of the central nervous system. Approximately 50 percent of pregnancies affected with NTDs may be prevented with adequate consumption of folic acid from 1 month before conception through the first 3 months of pregnancy.23 In 1992, the U.S. Public Health Service (PHS) recommended that all women of childbearing age consume 400 micrograms of folic acid daily.24 For women who already have had an NTD-affected pregnancy, PHS recommends that women consult with a health care professional about taking a much larger amount of folic acid—4,000 micrograms (4.0 milligrams)—when planning a pregnancy.24 In 1998, the Institute of Medicine further recommended that to reduce the risk of an NTD-affected pregnancy, all women capable of becoming pregnant should consume 400 micrograms of folic acid daily, from fortified foods or supplements or a combination of the two, in addition to consuming folate-rich foods, such as orange juice, green vegetables, and beans.
Most grain products (including enriched flour, breads, breakfast cereals, rice, and pasta) now are fortified with folic acid. However, the amount of folic acid that some segments of the reproductive-aged population might receive through their diet may not adequately meet the PHS recommendation of 400 micrograms daily. Thus, women capable of becoming pregnant need to review their dietary options, eat a diet that includes folate-rich foods, and target consumption of folic acid-fortified food as well as take a folic acid-containing supplement.
Prenatal Substance Exposure
16-17.	Increase abstinence from alcohol, cigarettes, and illicit drugs among pregnant women.
Target and baseline:
Objective	Increase in Reported Abstinence 
in Past Month From Substances 
by Pregnant Women*	1996–97 
Baseline (unless noted)	2010 
Target	
		Percent	
16-17a.	Alcohol	86	94	
16-17b.	Binge drinking	99	100	
16-17c.	Cigarette smoking†	87 (1998)	99	
16-17d.	Illicit drugs	98	100	

*Pregnant women aged 15 to 44 years.
†Smoking during pregnancy for all women giving birth in 1998 in 46 States, the District of Columbia, and New York City.

Target setting method: Better than the best for 16-17a and 16-17c; complete elimination for 16-17b and 16-17d.
Data sources: National Household Survey on Drug Abuse, SAMHSA for 16-17a, 16-17b, and 16-17d; National Vital Statistics System, CDC, NCHS for 16-17c.
Pregnant Women Aged 15 
to 44 Years, 1996–97 (unless noted)	16-17a.
Alcohol Abstinence, Past Month	16-17b.
No Binge Drinking, 
Past Month	16-17c.
No Cigarette Smoking, 1998*	16-17d.
No Drugs, Past Month	
	Percent	
TOTAL	86	99	87	98	
Race and ethnicity	
American Indian or Alaska Native	DNA	DNA	80	DNA	
Asian or Pacific Islander	DNA	DNA	97	DNA	
Asian	DNC	DNC	98	DNC	
Native Hawaiian and other Pacific Islander	DNC	DNC	84	DNC	
Black or African American	DNA	DNA	91	DNA	
White	DNA	DNA	86	DNA	
	
Hispanic or Latino	93	99	96	99	
Not Hispanic or Latino	DNA	DNA	86	DNA	
Black or African American	83	99	90	95	
White	85	99	84	98	
Education level (aged 18 to 44 years)	
Less than high school	79	99	78	92	
High school graduate	91	99	83	100	
At least some college	DNA	98	94	DNA	
College graduate	DNA	DNA	DNA	DNA	
Disability status	
Persons with disabilities	DNC	DNC	DNC	DNC	
Persons without disabilities	DNC	DNC	DNC	DNC	

DNA = Data have not been analyzed.  DNC = Data are not collected.  DSU = Data are statistically unreliable.
*Smoking during pregnancy for all women giving birth in 1998 in 46 States, the District of Columbia, and New York City.

A range of effects, including spontaneous abortion, LBW, and preterm delivery, have been associated with prenatal use of licit and illicit drugs, including alcohol, tobacco, cocaine, and marijuana., , , 20, 21, 22 As discussed above, tobacco is associated with LBW and spontaneous abortion.86 Heavy alcohol use is associated with FAS,87 and even moderate alcohol use has demonstrated effects on preterm delivery.88 The use of cocaine during pregnancy is associated with premature birth and impaired fetal growth.8, 20, 21, 22 In addition, women who use cocaine are at especially high risk of infectious diseases, including hepatitis B and HIV. Exposure to marijuana in utero may be associated with LBW, preterm birth, and neurobehavioral functioning. However, isolating the effects of marijuana use on newborns is difficult because users of the drug often use alcohol and tobacco as well.86 
Self-reported use of illicit drugs, such as cocaine and marijuana, is quite rare, with 98 percent of pregnant women reporting abstaining from these drugs. Rates of abstinence from harmful substances during pregnancy appear to be declining slowly. The use of alcohol during pregnancy, despite the established health risk, exemplifies this trend. In 1996–97, 86 percent of pregnant women abstained from alcohol use, an increase of 9 percent from the 1988 baseline. Rates of frequent drinking (at least seven drinks per week or at least five drinks on any occasion in the past month) among pregnant women have begun to decline, with only 1.3 percent of pregnant women reporting recent binge drinking in 1996–97, compared to 2.9 percent in 1994–95. Unintentional alcohol exposure is particularly likely to occur early in pregnancy, before a woman knows she is pregnant. In addition to the objectives presented here, objectives in Focus Area 26. Substance Abuse, address alcohol consumption among women of reproductive age and tobacco use by pregnant women.
16-18.	(Developmental) Reduce the occurrence of fetal alcohol syndrome (FAS).
Potential data source: Fetal Alcohol Syndrome Network (FASNet), CDC, NCEH.
FAS is one of the leading preventable causes of mental retardation and a leading cause of birth defects, including growth deficiency and microcephaly. Affected children also are likely to show infantile irritability, poor coordination, hypotonia, and attention deficit/hyperactivity disorder.88,  The diagnosis of FAS is based on three criteria: prenatal or postnatal growth retardation or both, central nervous system impairment, and characteristic facial malformations. Abnormalities of other organs and systems, however, have been noted in combination with these characteristics. Estimates of the cases of FAS vary from 0.2 to 1.0 per 1,000 live births. , ,  In addition to FAS, studies have documented more subtle growth and neurodevelopmental deficits among children whose mothers drank alcohol during pregnancy. Alcohol-related birth defects and alcohol-related neurodevelopmental disorders are thought to occur three to four times more often than diagnosed cases of FAS.94 Because of these lifelong effects, and because a safe level of alcohol consumption during pregnancy has not been identified, the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists recommend that women who are pregnant or are planning a pregnancy abstain from the use of alcohol., 
Despite broad agreement on the importance of FAS, consistent diagnosis of the syndrome at birth has been difficult to achieve. Thus, accurately estimating the number or proportion of infants affected by FAS is challenging for a number of reasons: the difficulty of evaluating an infant’s central nervous system, lack of training among clinicians, inconsistent diagnostic criteria, clinicians’ tendency to avoid associating their patients with the stigma of alcohol problems, and failures of mothers to report alcohol intake during gestation.7

Breastfeeding, Newborn Screening, and Service Systems
16-19.	Increase the proportion of mothers who breastfeed their babies.
Target and baseline:
Objective	Increase in Mothers Who Breastfeed	1998 Baseline	2010 Target	
		Percent	
16-19a.	In early postpartum period	64	75	
16-19b.	At 6 months	29	50	
16-19c.	At 1 year	16	25	

Target setting method: Better than the best.
Data source: Mothers’ Survey, Abbott Laboratories, Inc., Ross Products 
Division.
Mothers, 1998	Breastfed	
	16-19a.
Early 
Postpartum	16-19b.
6 Months	16-19c.
1 Year	
	Percent	
TOTAL	64	29	16	
Race and ethnicity	
American Indian or Alaska Native	DNC	DNC	DNC	
Asian or Pacific Islander	DNC	DNC	DNC	
Asian	DNC	DNC	DNC	
Native Hawaiian and other
Pacific Islander	DNC	DNC	DNC	
Black or African American	45	19	9	
White	68	31	17	
	
Hispanic or Latino	66	28	19	
Not Hispanic or Latino	DNC	DNC	DNC	
Black or African American	DNC	DNC	DNC	
White	DNC	DNC	DNC	
Education level	
Less than high school	48	23	17	
High school graduate	55	21	12	
At least some college	55	21	12	
College graduate	78	40	22	
Disability status	
Persons with disabilities	DNC	DNC	DNC	
Persons without disabilities	DNC	DNC	DNC	

DNA = Data have not been analyzed. DNC = Data are not collected. DSU = Data are statistically unreliable.

Breast milk is widely acknowledged to be the most complete form of nutrition for infants, with a range of benefits for infants’ health, growth, immunity, and development. The benefits of breastfeeding include decreased new cases or severity of diarrhea,25, 26, 27, 28, 36 respiratory infections,29, 30 and ear infections,26, 31, 32 among others, and reduced cost to the family.33, 34 In addition, breastfeeding has been shown to improve maternal health, with demonstrated effects, including reduction in postpartum bleeding,35 earlier return to prepregnancy weight,36 reduced risk of premenopausal breast cancer,37 and reduced risk of osteoporosis,38 continuing long after the postpartum period. In general, the American Academy of Pediatrics considers breastfeeding to be “the ideal method of feeding and nurturing infants.”10
Universal breastfeeding is not recommended in the United States. Women who use illicit drugs, who have active, untreated tuberculosis, or who test positive for HIV, as well as those who use certain prescribed drugs, should not breastfeed.11,  In general, however, increasing the rate of breastfeeding, particularly among low-income and certain racial and ethnic populations less likely to begin breastfeeding in the hospital or to sustain it throughout the infant’s first year, is an important public health goal. 
Rates of breastfeeding are highest among college-educated women and women aged 35 years and older. The lowest rates of breastfeeding are found among those whose infants are at highest risk of poor health and development: those aged 21 years and under and those with low educational levels. However, many of these groups have shown the greatest increase in breastfeeding rates since 1989. Rates of breastfeeding among African American women during the postpartum period increased 65 percent, and rates of African American women breastfeeding at 6 months grew 81 percent between 1988 and 1997. Breastfeeding rates among women aged 20 years and under at both periods also increased substantially, as did those among women with a grade-school education.12 While these improvements are encouraging, education of new mothers and their partners; education of health providers; changes in routine maternity ward practices; social support, including support from employers; and greater media portrayal of breastfeeding as the normal method of infant feeding are needed to increase breastfeeding rates among those at highest risk.
16-20.	(Developmental) Ensure appropriate newborn bloodspot screening, followup testing, and referral to services.
16-20a. Ensure that all newborns are screened at birth for conditions mandated by their State-sponsored newborn screening programs, for example, phenylketonuria and hemoglobinopathies.
16-20b. Ensure that followup diagnostic testing for screening positives is performed within an appropriate time period.
16-20c. Ensure that infants with diagnosed disorders are enrolled in appropriate service interventions within an appropriate time period.
Potential data source: Title V Performance Measures, HRSA, MCHB, National Newborn Screening and Genetic Resource Center.
Newborn screening (NBS) programs began in the early 1960s with the development of a screening test for phenylketonuria (PKU) and a system for blood sample collection on filter paper and transportation of that sample. Since then, all States and some territories of the United States have included NBS as part of their preventive public health system. NBS programs in the United States were the first population-based screening programs for genetic conditions and signaled the integration of genetic testing into public health programs. The mass screening of 4 million infants per year in the United States has been heralded as a successful program that is cost effective and reduces illness, disability, and death associated with inherited conditions. The universal acceptance of newborn screening for specified conditions since 1960 attests to the undeniable benefits that flow from testing and appropriate treatment and intervention.
The array of screening tests performed by each State varies and is changing constantly. All State programs now include screening for PKU and congenital hypothyroidism. More than 40 programs screen for sickle cell disease, and almost all screen for galactosemia. Others include congenital adrenal hyperplasia, homocystinuria, maple syrup urine disease, biotinidase deficiency, and tyrosinemia. A few States also include cystic fibrosis, additional metabolic disorders, and some other conditions such as congenital infections. Virtually all States treat or refer for treatment those with a confirmed diagnosis. However, some disorders are more uniformly screened for than others, and followup testing and early initiation of preventive treatment are uneven. For example, screening for PKU and congenital hypothyroidism is virtually universal, although reporting is not.,  Screening and followup for galactosemia, sickle cell disease, and other hemoglobinopathies have been less consistent.98, 99 Sickle cell disease can lead to severe illness and early death, and galactosemia leads to an increased risk of death from overwhelming infection in early infancy, failure to thrive, vomiting, liver disease, and mental retardation in untreated survivors. Therefore, it is vital that screening be universally available, that screening be of the highest quality, that diagnostic testing be provided for those newborns who screen positive, and that followup treatment be offered to children with diagnosed disorders., , 
16-21.	(Developmental) Reduce hospitalization for life-threatening sepsis among children aged 4 years and under with
sickling hemoglobinopathies.
Potential data source: National Hospital Discharge Survey (NHDS), CDC, NCHS.
Significant illness, disability, and death are associated with sickle cell disease because of increased susceptibility to severe bacterial infections—meningitis, pneumonia, and septicemia—all major causes of death among children with the disorder., ,  Life-threatening episodes of sepsis from pneumococcus and other organisms are well-recognized complications of sickle cell disease in children. The efficacy of daily oral penicillin prophylaxis in preventing infection among young children with sickle cell disease has been demonstrated.104 Sepsis rates have been shown to be clearly improved by prophylactic therapy in the U.S. penicillin trial, but concerns about actual use of penicillin in large populations and about penicillin-resistant organisms necessitate continued monitoring of sepsis rates in large populations. 
16-22.	(Developmental) Increase the proportion of children with special health care needs who have access to a medical home.
Potential data source: Title V Reporting System, HRSA, MCHB.
Historically, services for children with special health care needs have been difficult for families to access and for providers to coordinate. Families must navigate a variety of organizations and providers and often face geographic and financial barriers to care. Primary care providers in the community are not always comfortable providing care to children with complex needs, nor do they have time to coordinate the variety of resources families need. A lack of knowledge—of comprehensive needs and corresponding community-based resources and of payment mechanisms—presents a challenge for both families and providers. Poor communication between families and providers and cross-cultural misunderstandings are additional concerns for both families and providers.
Care for children with special health care needs should be provided and coordinated through a “medical home” that is accessible, family-centered, continuous, comprehensive, coordinated, compassionate, and culturally competent and linguistically appropriate. Physicians and parents share responsibility for ensuring that children and their families have access to all the medical and nonmedical services needed to help them achieve their maximum potential. The attributes of such a medical home are defined below:
•	Accessible care is care that is provided in the child’s community, in which all insurance, including Medicaid, is accepted and changes in insurance status are accommodated.
•	Family-centered care recognizes that the family is the principal caregiver and the center of strength and support for children. Family-centered services share unbiased and complete information with families on an ongoing basis.
•	Continuous care assures that the same primary pediatric health care professionals are available from infancy through adolescence and provide assistance with transitions (to home, school, and adult services).
•	Comprehensive health care is available 24 hours a day, 7 days a week, and addresses preventive, primary, and tertiary needs. 
•	Coordinated care links families to support, educational, and community-based services, and information is centralized.
•	Compassionate caregivers express concern for the well-being of the child and family.
•	Culturally appropriate and linguistically competent care recognizes, values, and respects the family’s cultural background., , , , 
16-23.	Increase the proportion of Territories and States that have service systems for children with special health care needs.
Target: 100 percent.
Baseline: 15.7 percent of Territories and States met Title V for service systems for children with special health care needs in FY 1997.
Target setting method: Total coverage.
Data source: Title V Block Grant Application Form 13, HRSA, MCHB.
Children with special health care needs and their families often require a range of services. Health services, for example, include health education and health promotion; preventive and primary care, including routine screening for impairments of vision, hearing, speech, and language, and assessment of physical and psychosocial milestones; specialized diagnostic and therapeutic services; and habilitation and rehabilitation services. Early intervention services are necessary as well, as are educational, vocational, and mental health services and support services for children and their families. Enabling services, such as transportation and child care, are necessary to ensure access to care. Transition services are needed to assist in the progression from adolescent health care to adult services and from school to work. 
Families continuously face the challenge of obtaining and coordinating the primary and special services their children require. Differing eligibility criteria, duplication and gaps in services, inflexible funding sources, and poor coordination among service sectors are some of the barriers consistently reported. Many of these issues can be resolved only through the concerted effort of a system of services—the broad array of public and private entities serving children and families in the Nation’s communities. These service systems should ensure access to a source of insurance for primary and specialty care and enabling services, an identified medical home, and care coordination. Families and their care professionals should participate in the design and implementation of these service systems. This collaborative partnership will strengthen the ability of families to care for their children with special needs and will enable children with complex conditions to live at home with their families.
Related Objectives From Other Focus Areas	
1.	 Access to Quality Health Services
1-1.	Persons with health insurance
1-2.	Health insurance coverage for clinical preventive services
1-4.	Source of ongoing care
1-5.	Usual primary care provider
1-6.	Difficulties or delays in obtaining needed health care
1-9.	Hospitalization for ambulatory-care-sensitive conditions
1-12.	Single toll-free number for poison control centers
1-13.	Trauma care systems
1-14.	Special needs of children 
5.	Diabetes
5-8.	Gestational diabetes
6.	Disability and Secondary Conditions
6-2.	Feelings and depression among children with disabilities
6-7.	Congregate care of children and adults with disabilities
6-9.	Inclusion of children and youth with disabilities in regular education 
programs 
7.	Educational and Community-Based Programs
7-1.	High school completion
7-2.	School health education
7-4.	School nurse-to-student ratio
8.	Environmental Health
8-11.	Elevated blood lead levels in children
8-20.	School policies to protect against environmental hazards
8-22.	Lead-based paint testing
9.	Family Planning
9-2.	Birth spacing
9-7.	Adolescent pregnancy
9-8.	Abstinence before age 15 years
9-9.	Abstinence among adolescents aged 15 to 17 years
9-10.	Pregnancy prevention and sexually transmitted disease (STD) protection
9-11.	Pregnancy prevention education

13.	HIV
13-17.	Perinatally acquired HIV infection
14.	Immunization and Infectious Diseases	
14-1.	Vaccine-preventable diseases
14-2.	Hepatitis B in infants and young children
14-18.	Antibiotics prescribed for ear infections
14-19.	Antibiotics prescribed for common cold
14-22.	Universally recommended vaccination of children aged 19 through 35 months of age
14-23.	Vaccination coverage for children in day care, kindergarten, and first grade
14-24.	Fully immunized young children and adolescents
14-25.	Providers who measure childhood vaccination coverage levels
14-26.	Children participating in population-based immunization registries 
14-27.	Vaccination coverage among adolescents
14-30.	Adverse events from vaccinations
14-31.	Active surveillance for vaccine safety
15.	Injury and Violence Prevention
15-1.	Nonfatal head injuries
15-2.	Nonfatal spinal cord injuries
15-3.	Firearm-related deaths
15-4.	Proper firearm storage in homes
15-5.	Nonfatal firearm-related injuries
15-7.	Nonfatal poisonings
15-8.	Deaths from poisoning
15-9.	Deaths from suffocation
15-10.	Emergency department surveillance systems
15-11.	Hospital discharge surveillance systems
15-12.	Emergency department visits
15-19.	Safety belts 
15-20.	Child restraints
15-23.	Bicycle helmet use
15-24.	Bicycle helmet laws
15-31.	Injury protection in school sports
15-33.	Maltreatment and maltreatment fatalities of children
15-38.	Physical fighting among adolescents
15-39.	Weapon carrying by adolescents on school property
18.	Mental Health and Mental Disorders
18-2.	Adolescent suicide attempts
18-5.	Eating disorder relapses 
18-7.	Treatment for children with mental health problems
18-8.	Juvenile justice facility screening 
19.	Nutrition and Overweight
19-3.	Overweight or obesity in children and adolescents
19-4.	Growth retardation in children
19-12.	Iron deficiency in young children and in females of childbearing age
19-13.	Anemia in low-income pregnant females
19-14.	Iron deficiency in pregnant females
19-15.	Meals and snacks at school

21.	Oral Health
21-1.	Dental caries experience
21-2.	Untreated dental decay
21-8.	Dental sealants
21-9.	Community water fluoridation
21-10.	Use of oral health care system
21-13.	School-based health centers with oral health component
21-14.	Health centers with oral health service components
21-15.	Referral for cleft lip or palate
21-16.	Oral and craniofacial State-based surveillance system
22.	Physical Activity and Fitness
22-6.	Moderate physical activity in adolescents
22-7.	Vigorous physical activity in adolescents
22-8.	Physical education requirement in schools
22-9.	Daily physical education in schools
22-10.	Physical activity in physical education class
22-11.	Television viewing 
22-12.	School physical activity facilities
24.	Respiratory Diseases
24-1.	Deaths from asthma
24-2.	Hospitalizations for asthma
24-3.	Hospital emergency department visits for asthma
24-5.	School or work days lost
25.	Sexually Transmitted Diseases
25-9.	Congenital syphilis
25-10.	Neonatal STDs
25-11.	Responsible adolescent sexual behavior
25-12.	Responsible sexual behavior messages on television
25-14.	Screening in youth detention facilities and jails
25-17.	Screening of pregnant women
26.	Substance Abuse
26-6.	Adolescents riding with a driver who has been drinking
26-9.	Substance-free youth
26-10.	Adolescent and adult use of illicit substances
26-14.	Steroid use among adolescents
26-15.	Inhalant use among adolescents
26-16.	Peer disapproval of substance abuse
26-17.	Perception of risk associated with substance abuse
27.	Tobacco Use
27-2.	Adolescent tobacco use
27-3.	Initiation of tobacco use
27-4.	Age at first use of tobacco
27-6.	Smoking cessation during pregnancy
27-7.	Smoking cessation by adolescents
27-11.	Smoke-free and tobacco-free schools
27-14.	Enforcement of illegal tobacco sales to minors laws
27-15.	Retail license suspension for sales to minors
27-17.	Adolescent disapproval of smoking
28.	Vision and Hearing
28-2.	Vision screening for children
28-4.	Impairment in children and adolescents
Terminology
(A listing of abbreviations and acronyms used in this publication appears in Appendix H.)
Anencephalus: Congenital absence of all or a major part of the brain.
Birth defect: An abnormality in structure, function, or body metabolism that is present at birth, such as cleft lip or palate, phenylketonuria, or sickle cell disease.
Breastfeeding: Exclusive use of human milk or use of human milk with a supplemental bottle of formula. “Exclusive breastfeeding” refers to the use of only human milk, supplemented by solid food when appropriate but not supplemented by formula.
Children with special health care needs: Children who have or are at risk for a chronic physical, developmental, behavioral, or emotional condition and who also require health care and related services of a type or amount beyond that required by children generally. 
Congenital anomaly: See birth defect.
Developmental disabilities: A broad spectrum of impairments characterized by developmental delay or limitation or both in personal activity, such as mental retardation, cerebral palsy, epilepsy, hearing and other communication disorders, and vision impairment. The more severe developmental disabilities require special interdisciplinary care.
Eclampsia/Preeclampsia: A condition that occurs in the second half of pregnancy, characterized by hypertension, edema, and proteinuria. When convulsions and coma are associated, it is called eclampsia.
Ectopic pregnancy: A gestation elsewhere than in the uterus, often occurring in the fallopian tube. An ectopic pregnancy cannot develop normally and causes fainting, abdominal pain, and vaginal bleeding.
Fetal alcohol syndrome (FAS): A cluster of structural and functional abnormalities found in infants and children as a result of alcohol consumption by the mother during pregnancy and characterized by growth retardation, facial malformations, and central nervous system dysfunction.
Fetal death: The death of a fetus in utero after 20 weeks or more of gestation. The fetal death rate is the number of fetal deaths in a population divided by the total number of live births and fetal deaths in the same population during the same time period.
Genetic disorders: The group of health conditions that result primarily from alterations in a gene or combination of genes.
Gestational trophoblastic disease: A type of cancer associated with pregnancy in which a grape-like mole develops in the womb.
Hydrocephalus: A condition marked by dilation of the cerebral ventricles accompanied by cerebrospinal fluid within the skull.
Hypotonia: A condition of diminished tone of the skeletal muscles, with diminished resistance of muscles to passive stretching.
Infant death: Death of an infant less than 1 year old. Neonatal death is the death of an infant less than 28 days after birth; postneonatal death is the death of an infant between 28 days and 1 year after birth.
Infant mortality rate: The number of deaths of infants less than 1 year old (obtained from death certificates) per 1,000 live births in a population (obtained from birth certificates). 
Intrapartum period: Period extending from the onset of labor through the completion of delivery.
Intrauterine growth retardation (IUGR): The failure of a fetus to maintain its expected growth potential at any stage of gestation. Infants with IUGR may be born at full term but are smaller than expected.
Level III hospital: A facility for high-risk deliveries and neonates that can provide care to very small infants, including mechanical ventilation and neonatal surgery and special care for transferred patients and for which a full-time neonatologist serves as the director.
Live birth: The complete expulsion or extraction from its mother of an infant, irrespective of the duration of pregnancy, which after such separation, breathes or shows any other evidence of life, such as the beating of the heart, pulsation of the umbilical cord, or definite movement of voluntary muscles, whether or not the umbilical cord has been cut or the placenta is attached. Each infant from such a birth is considered live born.
Low birth weight (LBW): Weight at birth of less than 2,500 grams (about 5.5 pounds).
Maternal death: Death of a woman while pregnant or within 42 days of the end of pregnancy, irrespective of the duration or site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes.
Maternal mortality rate: (also referred to as the maternal mortality ratio) Represents the number of maternal deaths for every 100,000 live births.
Medical home: Medical care for infants and children that is accessible, continuous, comprehensive, family-centered, coordinated, and compassionate.
Neonatal period: The first 28 days of life.
Neural tube defects (NTDs): A set of birth defects that result from failure of the neural tube to close in utero. Two of the most common NTDs are anencephaly (absence of the majority of the brain) and spina bifida (incomplete development of the back and spine).
Occurrence: As the term is used in this chapter, occurrence is the incidence of new cases among live births per year that are caused primarily by prenatal factors. In the spina bifida and other neural tube defects objective, identification is in the first year of life, and occurrence is reported as the number of cases per 10,000 live births per year. In the fetal alcohol syndrome objective, some children who have the condition at birth are not identified until age 4 or 5 years; occurrence is reported as a number per 10,000 live births. In the developmental disabilities objective, children with specified conditions such as mental retardation are not always identified until about age 7 or 8 years even though the conditions are usually caused by prenatal events; occurrence in these objectives is reported as a number per 10,000 children aged 8 years.
Perinatal death: Includes fetal deaths after 28 weeks of gestation and infant deaths within the first 7 days of birth. 
Postneonatal period: The period from an infant’s 29th day of life until the first birthday.
Postpartum period: The 6-week period immediately following birth.
Preeclampsia: (see eclampsia).
Prenatal care: Pregnancy-related health care services provided to a woman between conception and delivery. The American College of Obstetricians and Gynecologists recommends at least 13 prenatal visits in a normal 9-month pregnancy: one each month for the first 28 weeks of pregnancy, one every 2 weeks until 36 weeks, and then weekly until birth. 
Preterm birth: Birth occurring before 37 weeks of pregnancy.
Renal agenesis: Associated with duplicated vagina and uterus.
Sudden infant death syndrome (SIDS): Sudden, unexplained death of an infant from an unknown cause.
Surfactant: A surface-active agent that prevents the lungs from filling with water by capillary action.
Synthetic surfactant: An artificial substance that prevents a newborn’s lungs from filling with water.
Teratogenic: Causing malformations of an embryo or fetus.
Very low birth weight (VLBW): Weight at birth of less than 1,500 grams (about 3.3 pounds).
References